The Leeds, England-based company is an investor in UK and Northern European renewable energy assets. The trust reported a NAV per share at December 31 of 116.7 pence, down 0.8% from 117.7p the prior ...
Opus 2, a global legal software and services provider, is pleased to announce their continued partnership with Allen & Gledhill, one of the largest law firms in Asia, as they expand their use of Opus ...
Kunlun Tech officially launches the Mureka O1 and Mureka V6 models. As the world's first music reasoning large model, Mureka ...
Zacks Investment Research on MSN3d
James Hardie to Boost Market Expansion With the Acquisition of AZEKJames Hardie Industries plc JHX has entered into a definitive agreement with The AZEK Company Inc. AZEK to acquire it for a ...
TEMPO.CO, Jakarta - Tencent has introduced an Artificial Intelligence (AI) model called Hunyuan T-1, which is said to rival ...
Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the ...
Our interdisciplinary school is leading scientific exploration and engineering expertise in sustainability solutions, biomedical innovation and advanced materials. We address crucial issues like ...
R1's AI advancements in chemistry, math & coding. Click for my look at the AI field and what the innovations of DEEPSEEK mean ...
DHAHRAN, Saudi Arabia – Aramco, one of the world’s leading integrated energy and chemicals companies, has launched the ...
Si (silicon), a long-established semiconductor material, is utilized in the EcoMOS (TM) and EcoIGBT (TM) series of power semiconductors. Meanwhile, next-generation semiconductors such as EcoSiC (TM), ...
The Express Tribune on MSN9d
With Ramazan comes the spirit of givingThe ongoing economic crisis, characterised by skyrocketing prices and low income, has left many middle-class and low-income families struggling to meet their basic needs during the holy month of ...
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced expanded data in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback